[1]
Akhlaq, H. et al. 2021. Efficacy of Intravitreal Bevacizumab in Chronic Central Serous Chorioretinopathy in Terms of Mean Reduction of Central Macular Thickness in Pakistani Patients. Annals of Punjab Medical College. 14, 4 (Jan. 2021), 349–352. DOI:https://doi.org/10.29054/apmc/2020.576.